Parkinson Disease (immunology) < Parkinson Disease (metabolism) < Parkinson Disease (microbiology)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 290.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000015 (1999)	M. Ichise [Canada] ; Y J Kim ; S S Erami ; J R Ballinger ; D. Vines ; F. Tanaka ; A E Lang	Functional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-beta-CIT SPECT data.
000016 (1999)	M. Ichise [Canada] ; Y J Kim ; J R Ballinger ; D. Vines ; S S Erami ; F. Tanaka ; A E Lang	SPECT imaging of pre- and postsynaptic dopaminergic alterations in L-dopa-untreated PD.
000062 (1999)	L. Ste-Marie [Canada] ; L. Vachon ; C. Bémeur ; J. Lambert ; J. Montgomery	Local striatal infusion of MPP+ does not result in increased hydroxylation after systemic administration of 4-hydroxybenzoate.
000068 (2000)	C R Honey [Canada] ; M O Obochi ; H. Shen ; P. Margaron ; S. Yip ; J G Levy	Reduced xenograft rejection in rat striatum after pretransplant photodynamic therapy of murine neural xenografts.
000093 (2000)	C S Lee [Canada] ; A. Samii ; V. Sossi ; T J Ruth ; M. Schulzer ; J E Holden ; J. Wudel ; P K Pal ; R. De La Fuente-Fernandez ; D B Calne ; A J Stoessl	In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.
000098 (2000)	R. De La Fuente-Fernández [Canada] ; P K Pal ; F J Vingerhoets ; A. Kishore ; M. Schulzer ; E K Mak ; T J Ruth ; B J Snow ; D B Calne ; A J Stoessl	Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations.
000102 (2000)	R. De La Fuente-Fernández [Canada] ; A. Kishore ; D B Calne ; T J Ruth ; A J Stoessl	Nigrostriatal dopamine system and motor lateralization.
000104 (2000)	O G Rousset [Canada] ; P. Deep ; H. Kuwabara ; A C Evans ; A H Gjedde ; P. Cumming	Effect of partial volume correction on estimates of the influx and cerebral metabolism of 6-[(18)F]fluoro-L-dopa studied with PET in normal control and Parkinson's disease subjects.
000112 (????)	C. Schwab [Canada] ; A J Demaggio ; N. Ghoshal ; L I Binder ; J. Kuret ; P L Mcgeer	Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases.
000131 (2000)	A. Klegeris [Canada] ; P L Mcgeer	R-(-)-Deprenyl inhibits monocytic THP-1 cell neurotoxicity independently of monoamine oxidase inhibition.
000137 (2000)	H Y Choi [Canada] ; J H Song ; D K Park ; G M Ross	The effects of ascorbic acid on dopamine-induced death of PC12 cells are dependent on exposure kinetics.
000142 (2001)	B M Ross [Canada] ; N. Mamalias ; A. Moszczynska ; A H Rajput ; S J Kish	Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease.
000164 (2001)	M. Guttman [Canada] ; D. Stewart ; D. Hussey ; A. Wilson ; S. Houle ; S. Kish	Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD.
000167 (2001)	D J Doudet [Canada]	Monitoring disease progression in Parkinson's disease.
000175 (2001)	R. De La Fuente-Fernández [Canada] ; T J Ruth ; V. Sossi ; M. Schulzer ; D B Calne ; A J Stoessl	Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease.
000180 (2001)	W R Martin [Canada]	Magnetic resonance imaging and spectroscopy in Parkinson's disease.
000201 (2002)	Vesna Sossi [Canada] ; Raúl De La Fuente-Fernández ; James E. Holden ; Doris J. Doudet ; Jess Mckenzie ; A J Stoessl ; T J Ruth	Increase in dopamine turnover occurs early in Parkinson's disease: evidence from a new modeling approach to PET 18 F-fluorodopa data.
000203 (2002)	Frédéric Calon [Canada] ; Sam Birdi ; Ali H. Rajput ; Oleh Hornykiewicz ; Paul J. Bédard ; Thérèse Di Paolo	Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias.
000233 (2002)	Jonathan O. Dostrovsky [Canada] ; William D. Hutchison ; Andres M. Lozano	The globus pallidus, deep brain stimulation, and Parkinson's disease.
000235 (2002)	Raúl De La Fuente-Fernández [Canada] ; A Jon Stoessl	The placebo effect in Parkinson's disease.
000250 (2002)	D A Grimes [Canada] ; D E Bulman	Parkinson's genetics--creating exciting new insights.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Parkinson Disease (metabolism)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Parkinson Disease (metabolism)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease (metabolism)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022